My Fulbright research addresses the increasing problem of cancer survivors developing heart dysfunction later in life. I aim to validate a clinical risk score that helps identify which survivors will benefit most from heart failure screening. This collaboration with Memorial Sloan Kettering establishes an ongoing relationship with Australia’s largest cancer hospital
Dr. Joshua Wong is a cardiologist and PhD Research Fellow in Cardio-Oncology and Heart Failure at the Baker Heart and Diabetes Institute in Melbourne, Australia. He works clinically at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital.
As a Fulbright Scholar, Joshua will collaborate with world-experts in Cardio-Oncology at Memorial Sloan Kettering Cancer Centre in New York. His research focuses on developing tools which help identify which survivors are at greatest risk of cardiovascular disease. His passion is to prevent the cancer patient of today from becoming the heart failure patient
of tomorrow.